CollPlant Biotechnologies Ltd (CLGN)
5.40
+0.14
(+2.66%)
USD |
NASDAQ |
Apr 23, 16:00
5.30
-0.10
(-1.85%)
After-Hours: 20:00
CollPlant Biotechnologies Total Liabilities (Quarterly): 5.786M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.786M |
September 30, 2023 | 5.16M |
June 30, 2023 | 5.53M |
March 31, 2023 | 5.869M |
December 31, 2022 | 5.487M |
September 30, 2022 | 4.752M |
June 30, 2022 | 4.908M |
March 31, 2022 | 5.527M |
December 31, 2021 | 6.103M |
September 30, 2021 | 5.154M |
June 30, 2021 | 5.582M |
March 31, 2021 | 5.985M |
December 31, 2020 | 6.364M |
September 30, 2020 | 5.901M |
June 30, 2020 | 5.171M |
March 31, 2020 | 5.609M |
December 31, 2019 | 6.664M |
September 30, 2019 | 14.24M |
Date | Value |
---|---|
June 30, 2019 | 7.719M |
March 31, 2019 | 8.543M |
December 31, 2018 | 3.332M |
September 30, 2018 | 2.496M |
June 30, 2018 | 2.709M |
March 31, 2018 | 2.055M |
December 31, 2017 | 5.456M |
September 30, 2017 | 3.883M |
June 30, 2017 | 1.804M |
March 31, 2017 | 1.956M |
December 31, 2016 | 2.411M |
September 30, 2016 | 1.871M |
June 30, 2016 | 1.25M |
March 31, 2016 | 0.9488M |
December 31, 2015 | 0.9606M |
September 30, 2015 | 0.8445M |
June 30, 2015 | 0.6754M |
December 31, 2014 | 0.6798M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.752M
Minimum
Sep 2022
14.24M
Maximum
Sep 2019
6.185M
Average
5.609M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
Compugen Ltd | 55.78M |
Pluri Inc | 34.95M |
BioLine Rx Ltd | 50.70M |
Can Fite Biofarma Ltd | 3.746M |
BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 34.13M |
Shareholders Equity (Quarterly) | 28.34M |
Current Ratio | 8.620 |